Carlsmed appointed Jeffrey Bertolini chief operating officer effective September 8, 2026, raising his annual salary to $475,000 and granting 50,000 stock options. Investors also have a defined incentive structure to assess, with his target cash award rising to 60% of base salary as he assumes responsibility for operations.
Key Highlights
- Bertolini’s target annual cash incentive increased to 60% of base salary.
- Carlsmed granted the incoming chief operating officer 50,000 stock options.
- His employment terms provide salary continuation and incentive payments under specified termination conditions.
Carlsmed, Inc. (NASDAQ: CARL) appointed Jeffrey Bertolini chief operating officer effective September 8, 2026, increasing his annual salary to $475,000. The Leadership change also raises his target annual cash incentive to 60% of base salary and includes a grant of 50,000 stock options.
New COO Receives Expanded Compensation
Bertolini previously served as Carlsmed’s Senior Vice President of Operational Excellence and held its advanced Manufacturing technologies leadership role before that. His employment agreement originally set an annual base salary of $375,000 and a target incentive equal to 40% of base salary, while his salary had later risen to $440,000. The agreement provides for 12 months of continuing base salary after termination without cause or resignation for good reason outside a specified corporate transaction period, along with eligible incentive payments and COBRA reimbursements, subject to a release of claims. Carlsmed also entered into an indemnification agreement with Bertolini, and the company said no family relationships or other reportable material-interest arrangements applied.
Operations Role Targets Greater Scale
Carlsmed said Bertolini made measurable contributions to operations by deploying advanced technologies across its digital production process. Chief Executive Officer and President Michael Cordonnier said the company expects Bertolini’s leadership to expand capabilities and support faster scaling of its personalized surgery business.
FAQs
Q: Who is Carlsmed’s new chief operating officer?
A: Jeffrey Bertolini became Carlsmed’s chief operating officer effective September 8, 2026. He previously served as the company’s Senior Vice President of Operational Excellence.
Q: What compensation will Carlsmed’s COO receive?
A: Jeffrey Bertolini’s annual salary is $475,000, with a target cash incentive equal to 60% of base salary. Carlsmed also granted him 50,000 stock options.
Q: What changed in Jeffrey Bertolini’s compensation upon becoming COO?
A: Jeffrey Bertolini became Carlsmed’s chief operating officer effective September 8, 2026. His annual salary increased to $475,000, with a target cash incentive of 60% and 50,000 stock options.
Q: What experience does Bertolini bring to the COO role?
A: Bertolini previously served as Senior Vice President of Operational Excellence and led advanced manufacturing technologies. Carlsmed credited him with deploying advanced technologies across its digital production process.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.